Ager S, Broadbent V, Marcus R E
Department of Haematology, Addenbrooke's Hospital, Cambridge, England, UK.
Leuk Lymphoma. 1995 Jul;18(3-4):349-51. doi: 10.3109/10428199509059629.
Twenty patients with acute leukaemia in second or greater complete remission have undergone autologous bone marrow transplantation (ABMT) in our centre. Twelve patients had acute myeloid leukaemia (AML) and eight patients had acute lymphoblastic leukaemia (ALL). Six of the patients treated for AML remain in CR. Of the eight patients with ALL, all have died within one year of transplantation. In the patients with AML there was no relationship between the duration of previous CR and outcome of ABMT.
在我们中心，20例处于第二次或更高级别完全缓解期的急性白血病患者接受了自体骨髓移植（ABMT）。其中12例为急性髓系白血病（AML）患者，8例为急性淋巴细胞白血病（ALL）患者。接受AML治疗的患者中有6例仍处于完全缓解期。在8例ALL患者中，所有患者均在移植后一年内死亡。在AML患者中，既往完全缓解期的持续时间与ABMT的结果之间没有关联。
